USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 60,871 shares of the stock in a transaction dated Thursday, October 26th. The shares were sold at an average price of $67.39, for a total transaction of $4,102,096.69. Following the completion of the transaction, the insider now directly owns 12,089,267 shares of the company’s stock, valued at $814,695,703.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Monday, October 30th, Global Ltd Gull sold 93,443 shares of USANA Health Sciences stock. The shares were sold at an average price of $67.08, for a total transaction of $6,268,156.44.
  • On Thursday, September 14th, Global Ltd Gull sold 79,294 shares of USANA Health Sciences stock. The shares were sold at an average price of $57.61, for a total transaction of $4,568,127.34.
  • On Tuesday, September 5th, Global Ltd Gull sold 40,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $58.41, for a total transaction of $2,336,400.00.
  • On Wednesday, August 2nd, Global Ltd Gull sold 14,533 shares of USANA Health Sciences stock. The shares were sold at an average price of $56.71, for a total transaction of $824,166.43.
  • On Tuesday, August 1st, Global Ltd Gull sold 25,467 shares of USANA Health Sciences stock. The shares were sold at an average price of $56.52, for a total transaction of $1,439,394.84.

Shares of USANA Health Sciences, Inc. (USNA) opened at 65.90 on Tuesday. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $71.00. The stock has a 50 day moving average of $59.68 and a 200 day moving average of $60.77. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of 17.12 and a beta of 1.09.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.11. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.54%. The business had revenue of $261.77 million for the quarter, compared to the consensus estimate of $259.52 million. During the same period in the previous year, the firm earned $2.40 EPS. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, analysts predict that USANA Health Sciences, Inc. will post $3.87 EPS for the current fiscal year.

USANA Health Sciences announced that its board has approved a share repurchase program on Tuesday, July 25th that allows the company to repurchase $64.60 million in outstanding shares. This repurchase authorization allows the company to purchase up to 46% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: “USANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 60,871 Shares of Stock” was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright legislation. The original version of this article can be viewed at https://theolympiareport.com/2017/10/31/usana-health-sciences-inc-usna-major-shareholder-global-ltd-gull-sells-60871-shares-of-stock.html.

Several analysts have recently commented on the stock. BidaskClub lowered shares of USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research report on Monday, July 31st. Pivotal Research increased their price target on shares of USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, October 25th.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. American International Group Inc. raised its holdings in shares of USANA Health Sciences by 7.1% in the 1st quarter. American International Group Inc. now owns 6,392 shares of the company’s stock worth $368,000 after purchasing an additional 422 shares in the last quarter. Schroder Investment Management Group increased its position in shares of USANA Health Sciences by 9.0% in the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after acquiring an additional 47,448 shares in the last quarter. Trust Co. of Vermont increased its position in shares of USANA Health Sciences by 482.7% in the third quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after acquiring an additional 3,900 shares in the last quarter. FMR LLC increased its position in shares of USANA Health Sciences by 3.9% in the second quarter. FMR LLC now owns 1,598,143 shares of the company’s stock worth $102,441,000 after acquiring an additional 60,033 shares in the last quarter. Finally, PDT Partners LLC increased its position in shares of USANA Health Sciences by 41.6% in the second quarter. PDT Partners LLC now owns 24,500 shares of the company’s stock worth $1,570,000 after acquiring an additional 7,200 shares in the last quarter. Institutional investors and hedge funds own 44.62% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.